Skip to main content

Crescent Capital Group Closes €3B Third European Specialty Lending Fund

Press releases | April 10, 2025

Fried Frank acted as counsel to Crescent Capital Group LP, a leading alternative credit investment firm, on the fundraising of its third European specialty lending fund, Crescent European Specialty Lending Fund III (“CESL III”), which final closed with total investable capital of approximately €3 billion, including targeted leverage and separately managed accounts investing alongside the fund. CESL III was oversubscribed, exceeding its initial target of €2 billion. 

This fundraise represents a significant increase from its predecessor fund, Crescent European Specialty Lending Fund II, which final closed at €1.8 billion of investable capital and which Fried Frank also advised on.

CESL III will continue Crescent’s strategy of investing primarily in a diversified portfolio of private secured debt securities issued by European companies, with a focus on directly originated transactions. CESL III is actively investing and has committed approximately €800 million across 16 transactions.

The Fried Frank team was led by corporate partners Kate Downey and Robert MacVicar.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.